Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02038647
Brief Title: Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC)

First Submitted : December 4, 2013
First Submitted that Met QC Criteria : January 14, 2014
First Posted : January 16, 2014 (Estimate)

Results First Submitted : February 21, 2018
Results First Submitted that Met QC Criteria : December 3, 2018
Results First Posted : December 27, 2018

Last Update Submitted that Met QC Criteria : December 3, 2018
Last Update Posted : December 27, 2018